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Abstract 
Background: To audit the practices involved in 
management of pneumonia patients in our settings 
and to compare them with standard recommended 
guidelines by British Thoracic Society (BTS). 
Methods: In this cross sectional study  inclusion 
criteria was all patients admitted  with suspicion of 
lower respiratory infection/pneumonia, with no 
exclusion. Clinical presentation ,  diagnostic workup, 
treatment modalities  and  complications were  
analyzed.  
Results: Majority (97.3%) of the patients were 
admitted through emergency. Length of stay was less 
than 1 week in 72%. CURB-65 was applied in 2.6%. 
Majority (96% ) patients had inadequate 
investigations. Most commonly prescribed first line 
antibiotic was Cephalosporins given to 56%.. Co-
morbidities were registered in  96%, which 
contributed towards expiry rate of 60%.  
Conclusion: The management of pneumonia 
patients in our settings is not in line to the 
recommended standard guidelines . This results in 
increased complications, prolonged hospital stay and 
an overall poor prognosis.   
Key Words: Pneumonia, Community acquired, 
Streptocaus  pnuemiae 
 
Introduction 
Pneumonia is the infection of lower respiratory tract 
and constitutes a major fraction of patients admitted in 
hospitals.  1 This infectious disease is  one of the 
common reason of morbidity and mortality in both 
developed and developing countries.2-,4 In Pakistan 
situation is quite alarming. The range of overall annual 
incidence of community acquired pneumonia (CAP) in 
adults in Europe existed between 1.07 to 1.2 per 1000 
person –years and 1.54 to 1.7 per 1000 population. 
With age, the incidence of CAP increased (14 per 1000 
person-years in adults aged greater than 65). More 
men were affected than women and patients with 
chronic respiratory disease or HIV infection had 
higher occurrence. 5 
Community acquired pneumonia and nosocomial 
pneumonia are the two types of pneumonia. Most 
common causative organisms are S. pneumoniae, 
Haemophilus influenzae, Aerobic gram negative rods 
and S. aureus. The symptoms of CAP  are fever and 
chills, cough, rapid breathing or difficulty breathing. 
The most common causative organism according to a 
literature review of 41 European studies is 
Streptococcus pneumoniae followed by Mycoplasma 
pneumoniae, Chlamydophila pneumoniae, Legionella 
pneumophila and Haemophilus influenzae  but in Asia 
situation is quite different. 6 Most common causative 
organism is Streptococcus pneumonia 13.3%, followed 
by gram negative bacteria (only Enterobacteriaceae) 
9.0%, mycoplasma pneumonia 8.3%, Chlamydophila 
pneumoniae 6.9%, Staphylococcus aureus 4.0%, 
Haemophilus influenzae6.9%, Legionella species 
3.0%.7  
Complications vary from life threatening comprises to 
massive pleural effusion, hypotension, lung abscess, 
lung cavitation, sepsis with  shock, and acute 
respiratory failure ,often requiring admissions in high 
dependency units. 8-10 Other complications which are 
hardly of any clinical consequences include mild 
confusion, mild jaundice, haemoptysis, mild anaemia, 
and arthritis.8- 11  To determine the rate of mortality in 
patients with low risk factors, pneumonia severity 
index is applied. The range of mortality existed from 
0.1 to 0.4 percent for class I patients , from 0.6 to 0.7 
percent for class II , and from 0.9 to 2.8 percent for 
class III. 12,13  
Pneumonia is defined as acute lung parenchymal 
infection caused by single or multi infectious 
pathogens excluding the bronchiolitis condition, the 
causative organism of bronchiolitis is always viral. 13 
CAP is  defined as acute lung parenchymal infection 
caused by single or multi infectious pathogens  
associated with its  signs and symptoms with chest 
radiographs showing acute infiltrate in patient who 
has no history of hospital stay for last 14 days.14,15 
Patients and Methods  
This cross sectional study  was conducted in South 
Medical Department of Mayo Hospital Lahore , from  
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November 2017 to January, 2018. Using the confidence 
level of 95% and precision of 5% with prevalence of 
stroke in Pakistan being 4.8%, sample size calculated  
was 70.Inclusion criteria was all patients admitted in 
Mayo hospital with suspicion of lower respiratory 
infection/pneumonia, with no exclusion. Clinical 
presentation, diagnostic workup, treatment modalities 
 and complications were  analyzed. All collected data 
was entered and analysed by  SPSS 21. 
 
Results 
Shortness of breath ( 85.33%) and cough (76.0%) were 
the commonest complaints (Table 1).  Hypertension 
(74.6) and Diabetes Mellitus (70.6%) were more 
prevalent co-morbidities (Table 2). Majority (97.0%) 
were admitted through emergency room. Forty 
percent were shifted to ICU. Forty five (60%) expired 
(Table 3). Chest X-ray was most frequently done 
investigation(93.3%) and ABGs were done in (86.6%).  
 
Table 1: Pneumonia- Presenting complaints  
Presenting complaint No(%) 
Shortness of breath 64(85.3) 
Cough 57(76) 
Fever 34(45.3) 
Expectoration 42(56) 
 Hemoptysis  6 (8) 
Others 37(49.3) 
 
Table 2.Pneumonia-Co-morbidities 
Co-morbidities No(%) 
Hypertension 56(74.6) 
Diabetes Mellitus 53(70.6) 
Chronic Obstructive Lung Disease 27(36) 
Tuberculosis 16(21.3) 
Asthma 11(14.6) 
Others 41(54.6) 
 
Table 3. Pneumonia- mode of admission, 
hospital stay and outcome 
Parameter No (%) 
Mode of 
admission 
Out  Patient 
Department 
2(2.66) 
Emergency 73(97.33) 
Length of 
stay 
< 1week 54(72) 
> week 21(28) 
ICU  
admission 
Required 30(400 
Not required 45(60) 
Outcome Discharged 30(40) 
 Expired 45(60) 
 
Table 4.  Pneumonia –Investigation implicated 
in the management 
 Frequency  Percentage 
   Chest X-ray            70           93.3 
       ABGs            65          86.66 
     CT Scan            15            20 
     ESR/CRP             7            9.3 
    Sputum C/S            24            32 
     Blood C/S             4            5.3 
      CURB-65             2            2.6 
    Vaccination             4            5.3 
 
Table 5. Pneumonia- Antibiotics employed  
                                       
               
     Frequency of patients 
1st 
line 
antib-
iotic 
2nd 
line 
antib-
iotic 
3rd line 
antibiotic 
4th line 
antibiotic 
 
 
 
Group of 
Antibiotics 
Cephlos
porins 
    42   6 -   - 
Quinolo
nes 
  11 32     6     2 
Cephlo-
sporins 
and 
quinol-
ones 
   17   -       -   - 
Macrol-
ides 
     -  2   9   - 
Penicillin 
   
derivativ
es 
4 4  - 6 
   
Others  
1 11 5 6 
  None  - 
 
    20     55     67 
 
Table 6. Pneumonia – complications 
Complication Frequency Percentage 
ARDS 21 28.0 
Atrial fibrillation 3 4.0 
Sepsis 14 18.7 
ARDS and Sepsis 8 10.7 
A.fib and Sepsis 1 1.3 
None 28 37.3 
Total 75 100 
Blood culture, sputum culture, CT scan, ESR and 
vaccination were included in the management of very 
little number of patients. CURB-65 was applied in only 
2 patients (2.6%) (Table 4).Most commonly prescribed 
first line antibiotic was Cephalosporins alone  in 56% 
(Table 5). Most common complication was ARDS 
(28%), next common being the sepsis (18.6%) (Table 6). 
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Discussion 
Pneumonia is 4th most common cause of mortality 
according to global burden of disease study conducted 
in 2010 [2]. According to a survey, about one million 
people expire with community acquired pneumonia in 
Asia annually. Most of the people who die due to CAP 
belong to older age group i.e. above 60 years but  
people having age between 15-59 years with good life 
expectancy contribute a large fraction as well. 16. 
According to British Thoracic Society (BTS) CURB-65 
scoring system.17 Patients with community acquired 
pneumonia were classified into low, intermediate, and 
high risk groups. So, patients should be treated 
according to BTS protocol. 18- 20 It is observed that risk 
of community acquired pneumonia is increased by 
many folds if the patient has other chronic illness like 
COPD, cardiovascular diseases, cerebrovascular 
disease, Parkinson's disease, hypothermia,malignancy, 
dysphagia, HIV or chronic renal or liver disease. 5,21,22 
The purpose of this audit was to identify the 
deficiency in diagnosis and management of 
pneumonia in addition to the evaluations of risk 
factors, way of presentation, gender distribution and 
the final outcome.The local practises involved were 
compared with the International Standardized 
guidelines.After evaluating the results, we have 
identified deficiencies in the investigations carried out 
and the type of antibiotics used.  It was observed that 
patients with advanced age and co-morbidities had 
high mortality and prolonged hospital stay. Apart 
from Chest X Rays and ABGs rest of the investigations 
protocol were not carried out fully as recommended. 
CURB 65 scoring was done only in 2 patients. Despite 
people being admitted to HDU/ICU,blood and 
sputum cultures were done only in few patients.  
Broad spectrum antibiotics use, abuse and misuse for 
CAP like common infection is very dangerous 
particularly in Asia where mortality rate is high, there 
is shortage of resources  and resistance to 
antibiotics.23,24 In these patients choice of antibiotics is 
not usually followed as par the recommendations. 
Hospital follow up was advised only to 30% of 
patients. The overall effect of these factors is increase 
in mortality.It is also noticed that presence of co-
morbidities and advanced age is also a significant risk 
factor towards a high mortality rate. 
The reason for these deficiencies as described above is 
multifactorial and reflects poorly on the quality of 
service delivered in a  tertiary care hospital. The major 
reason for this is the lack of standardization of  
hospital protocols,gaps in the knowledge of junior 
doctors,inadequate supervision and guidance, delay 
on the part of patient and families in seeking medical 
advice and lastly excessive work load on junior 
doctors in Emergency Department 
It is therefore recommended that junior doctors 
involved in managing these patients need to update 
their knowledge and refresh their skills. Input from 
senior consultants should be sought at a much earlier 
stage. An investigation protocol for all pneumonia 
patients should be in place and strictly adhered to. 
Initial evaluation using CURB 65 Score should be 
made mandatory in all patients above 65, which will 
help in identifying patients with advanced disease and 
needing High Dependency Care at an earlier stage.The 
guidelines should be regularly updated keeping in 
view the availability of new drugs and also presence of 
drug resistant strains 
 
Conclusion 
The management of pneumonia patients in our 
settings is not in line to the recommended standard 
guidelines . This results in increased complications, 
prolonged hospital stay and an overall poor prognosis.  
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